385 related articles for article (PubMed ID: 1900665)
1. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
Milsom I; Andersson K; Andersch B; Rybo G
Am J Obstet Gynecol; 1991 Mar; 164(3):879-83. PubMed ID: 1900665
[TBL] [Abstract][Full Text] [Related]
2. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia.
Andersson JK; Rybo G
Br J Obstet Gynaecol; 1990 Aug; 97(8):690-4. PubMed ID: 2119218
[TBL] [Abstract][Full Text] [Related]
3. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
Irvine GA; Campbell-Brown MB; Lumsden MA; Heikkilä A; Walker JJ; Cameron IT
Br J Obstet Gynaecol; 1998 Jun; 105(6):592-8. PubMed ID: 9647148
[TBL] [Abstract][Full Text] [Related]
4. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability.
Tang GW; Lo SS
Contraception; 1995 Apr; 51(4):231-5. PubMed ID: 7796588
[TBL] [Abstract][Full Text] [Related]
5. The levonorgestrel intrauterine system in the management of menorrhagia.
Barrington JW; Bowen-Simpkins P
Br J Obstet Gynaecol; 1997 May; 104(5):614-6. PubMed ID: 9166207
[TBL] [Abstract][Full Text] [Related]
6. Hormonal intrauterine devices.
Rybo G; Andersson K; Odlind V
Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
[TBL] [Abstract][Full Text] [Related]
7. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
[TBL] [Abstract][Full Text] [Related]
8. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
[TBL] [Abstract][Full Text] [Related]
9. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
10. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid: a review of its use in the management of menorrhagia.
Wellington K; Wagstaff AJ
Drugs; 2003; 63(13):1417-33. PubMed ID: 12825966
[TBL] [Abstract][Full Text] [Related]
12. Five years' experience with levonorgestrel-releasing IUDs.
Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
[TBL] [Abstract][Full Text] [Related]
13. Patterns of bleeding and body iron stores during the use of a levonorgestrel-releasing intracervical device.
Ratsula K; Toivonen J; Allonen H
Contraception; 1988 Sep; 38(3):333-40. PubMed ID: 3139362
[TBL] [Abstract][Full Text] [Related]
14. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
Fong YF; Singh K
Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
[TBL] [Abstract][Full Text] [Related]
15. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
16. An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia.
Andersch B; Milsom I; Rybo G
Acta Obstet Gynecol Scand; 1988; 67(7):645-8. PubMed ID: 3073625
[TBL] [Abstract][Full Text] [Related]
17. Decline in Danish use of oral tranexamic acid with increasing use of the levonorgestrel-releasing intrauterine system: a nationwide drug utilization study.
Meaidi A; Kuhr Skals R; Alexander Gerds T; Lidegaard O; Torp-Pedersen C
Contraception; 2020 May; 101(5):321-326. PubMed ID: 31935386
[TBL] [Abstract][Full Text] [Related]
18. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days.
Johannisson E; Brosens I; Cornillie F; Elder M; White J; Sheppard B; Hourihan H; d'Arcangues C; Belsey EM
Contraception; 1991 Apr; 43(4):361-74. PubMed ID: 1906792
[TBL] [Abstract][Full Text] [Related]
19. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices.
Ylikorkala O; Viinikka L
Br J Obstet Gynaecol; 1983 Jan; 90(1):78-83. PubMed ID: 6336951
[TBL] [Abstract][Full Text] [Related]
20. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
